Solvay reports preliminary Q3 2026 results and updates full-year 2026 guidance

Summary by AI BETAClose X

Solvay has reported preliminary Q3 2026 results showing underlying net sales of €1.03 billion, underlying EBITDA of €173 million, and free cash flow to shareholders of €54 million, impacted by the Middle East conflict and a peroxide plant shutdown in Saudi Arabia. Consequently, the company has updated its full-year 2026 guidance, excluding potential Sadara recovery measures, to an underlying EBITDA between €720 million and €740 million, and free cash flow between €120 million and €150 million.

Disclaimer*

Companies

Solvay SA (0NZR)
UK 100

Latest directors dealings